Agenda

THURSDAY, DECEMBER 6, 2018

Agenda subject to change. All times are listed in Pacific Standard Time (PST).
7:30 AM - 1:00 PM
Registration
7:30 AM - 8:30 AM
Continental Breakfast
8:30 AM - 8:50 AM
Welcome and Opening Remarks
8:55 AM - 9:25 AM
Opening Keynote

Helmy Eltoukhy, PhD, Co-Founder and Chief Executive Officer, Guardant Health
9:30 AM - 10:20 AM
FINANCING AND VENTURE CAPITAL PANEL
Personalized Medicine Investors: Who Are They and What Are They Thinking?

Alexis Ji, PhD, MBA, Partner, Illumina Ventures
Patricia Lawman, PhD, Chief Executive Officer, Morphogenesis
J. Blake Long, MD, Investor Member, Ariel Southeast Angel Partners & President, Long Health Care Consulting
Jonathan Norris, Managing Director of Sales Origination, Silicon Valley Bank
MODERATOR | Curt P. Creely, Partner, Foley & Lardner LLP
10:20 AM - 10:50 AM
Networking Break
10:50 AM - 11:40 AM
BIG DATA PANEL
Exploiting AI: From Discovery to Treatment

Blanca Baez, MBA, Senior Vice President & Global Head of Pharma and Biotech, Molecular Health
David Hardison, PhD, Vice President, Health Sciences, ConvergeHEALTH by Deloitte
Girish Putcha, MD, PhD, Chief Medical Officer and Clinical Laboratory Director, Freenome
Jo Varshney, DVM, PhD, Founder and Chief Executive Officer, VeriSIM Life
MODERATOR | Matt Gardner, Founder and Chief Executive Officer, California Technology Council
11:45 AM - 12:35 PM
DISRUPTIVE INNOVATION PANEL
Disruptive Technologies Creating Revolutionary Opportunities

Mickey Kertesz, PhD, Chief Executive Officer, Karius
James S. Scibetta, Chief Executive Officer, Maverick Therapeutics
MODERATOR | Ashley Van Zeeland, PhD, MBA, Vice President, Product Development, Business Operations, and Systems Integration, Illumina
12:35 PM - 1:35 PM
Luncheon
1:35 PM - 2:15 PM
LEGAL ISSUES PANEL
Anticipating and Addressing Legal Issues in Growth and Development

Jennifer Dyer, Executive Director, USC Stevens Center for Innovation
Richard A. Kaufman, Partner & Life Sciences Industry Team Co-Chair, Foley & Lardner LLP
Antoinette F. Konski, Partner & Life Sciences Industry Team Co-Chair, Foley & Lardner LLP
2:20 PM - 3:10 PM
FDA REGULATORY PANEL
Collaborating With the FDA: What Has Worked and What Hasn't?

Neena Patil, Senior Vice President & General Counsel, Abeona Therapeutics
Rizwana F. Sproule, PhD, Senior Vice President, Regulatory Affairs, Kite Pharma
MODERATOR | Nathan A. Beaver, Partner, Foley & Lardner LLP
3:10 PM - 3:40 PM
Networking Break
3:40 PM - 4:30 PM
PAYMENT AND REIMBURSEMENT PANEL
Reimbursement: The Best-Laid Plans?

Anita J. Chawla, PhD, Managing Principal, Analysis Group
Marcy Imada, Principal, Deloitte & Touche LLP
Mark McCoy, MBA, Vice President, Reimbursement, Guardant Health
Bruce Quinn, MD, PhD, Principal, Bruce Quinn Associates LLC
MODERATOR | Judith A. Waltz, Partner, Foley & Lardner LLP
4:35 PM - 5:25 PM
CLINICAL ADOPTION PANEL
The Business of Integration: Exploring the Clinical Adoption Models of Three Distinct Institutions

Thomas Brown, MD, Executive Director, Swedish Cancer Institute & Co-Chairman, Providence Health & Services Personalized Medicine Program
James Ford, MD, Director, Clinical Cancer Genetics Program, Stanford Health Care & Associate Professor of Medicine and Genetics, Stanford University School of Medicine
Lincoln Nadauld, MD, PhD, Executive Director, Personalized Medicine and Precision Genomics, Intermountain Healthcare
MODERATOR | Edward Abrahams, PhD, President, Personalized Medicine Coalition
5:30 PM - 6:00 PM
Closing Keynote

Harry Glorikian, MBA, Senior Executive, Board Director, Consultant, Investor, and Author of “MoneyBall Medicine”
6:00 PM - 7:00 PM
Closing Remarks and Reception
 

Past Agendas:

2013 2014 2015 2017